Attached files

file filename
10-K - FORM 10-K - NOVELION THERAPEUTICS INC.d293106d10k.htm
EX-21 - EXHIBIT 21 - NOVELION THERAPEUTICS INC.d293106dex21.htm
EX-11 - EXHIBIT 11 - NOVELION THERAPEUTICS INC.d293106dex11.htm
EX-31.2 - EXHIBIT 31.2 - NOVELION THERAPEUTICS INC.d293106dex312.htm
EX-32.1 - EXHIBIT 32.1 - NOVELION THERAPEUTICS INC.d293106dex321.htm
EX-31.1 - EXHIBIT 31.1 - NOVELION THERAPEUTICS INC.d293106dex311.htm
EXCEL - IDEA: XBRL DOCUMENT - NOVELION THERAPEUTICS INC.Financial_Report.xls
EX-32.2 - EXHIBIT 32.2 - NOVELION THERAPEUTICS INC.d293106dex322.htm

EXHIBIT 23

CONSENT OF INDEPENDENT REGISTERED CHARTERED ACCOUNTANTS

We consent to the incorporation by reference in the Registration Statement Nos. 333-2488, 333-12422, 333-100070, 333-120657 and 333-162465 of QLT Inc. on Form S-8 of our reports dated February 23, 2012, relating to the consolidated financial statements and financial statement schedule of QLT Inc. and the effectiveness of internal control over financial reporting appearing in the Annual Report on Form 10-K of QLT Inc. for the year ended December 31, 2011.

/s/ DELOITTE & TOUCHE LLP

Independent Registered Chartered Accountants

Vancouver, Canada

February 23, 2012